595 related articles for article (PubMed ID: 19546417)
1. The frequency of hyperkalemia and its significance in chronic kidney disease.
Einhorn LM; Zhan M; Hsu VD; Walker LD; Moen MF; Seliger SL; Weir MR; Fink JC
Arch Intern Med; 2009 Jun; 169(12):1156-62. PubMed ID: 19546417
[TBL] [Abstract][Full Text] [Related]
2. Hyperkalemia-Related Discontinuation of Renin-Angiotensin-Aldosterone System Inhibitors and Clinical Outcomes in CKD: A Population-Based Cohort Study.
Leon SJ; Whitlock R; Rigatto C; Komenda P; Bohm C; Sucha E; Bota SE; Tuna M; Collister D; Sood M; Tangri N
Am J Kidney Dis; 2022 Aug; 80(2):164-173.e1. PubMed ID: 35085685
[TBL] [Abstract][Full Text] [Related]
3. Serum potassium in stage 5 CKD patients on their first presentation in a dialysis service of a county hospital in western Romania.
Gluhovschi G; Mateş A; Gluhovschi C; Golea O; Gădălean F; Somai M; Ene I; Petrica L; Velciov S
Rom J Intern Med; 2014; 52(1):30-8. PubMed ID: 25000676
[TBL] [Abstract][Full Text] [Related]
4. Serum Potassium, End-Stage Renal Disease and Mortality in Chronic Kidney Disease.
Nakhoul GN; Huang H; Arrigain S; Jolly SE; Schold JD; Nally JV; Navaneethan SD
Am J Nephrol; 2015; 41(6):456-63. PubMed ID: 26228532
[TBL] [Abstract][Full Text] [Related]
5. Association between Serum Potassium and Outcomes in Patients with Reduced Kidney Function.
Luo J; Brunelli SM; Jensen DE; Yang A
Clin J Am Soc Nephrol; 2016 Jan; 11(1):90-100. PubMed ID: 26500246
[TBL] [Abstract][Full Text] [Related]
6. Association of hyperkalemia with clinical outcomes in advanced chronic kidney disease.
Caravaca-Fontán F; Valladares J; Díaz-Campillejo R; Barroso S; Luna E; Caravaca F
Nefrologia (Engl Ed); 2019; 39(5):513-522. PubMed ID: 31027897
[TBL] [Abstract][Full Text] [Related]
7. Effect of Patiromer in Hyperkalemic Patients Taking and Not Taking RAAS Inhibitors.
Kloner RA; Gross C; Yuan J; Conrad A; Pergola PE
J Cardiovasc Pharmacol Ther; 2018 Nov; 23(6):524-531. PubMed ID: 30103622
[TBL] [Abstract][Full Text] [Related]
8. Effect of Patiromer on Serum Potassium Level in Patients With Hyperkalemia and Diabetic Kidney Disease: The AMETHYST-DN Randomized Clinical Trial.
Bakris GL; Pitt B; Weir MR; Freeman MW; Mayo MR; Garza D; Stasiv Y; Zawadzki R; Berman L; Bushinsky DA;
JAMA; 2015 Jul; 314(2):151-61. PubMed ID: 26172895
[TBL] [Abstract][Full Text] [Related]
9. Hyperkalemia in patients with chronic renal failure.
Seliger SL
Nephrol Dial Transplant; 2019 Dec; 34(Suppl 3):iii12-iii18. PubMed ID: 31800076
[TBL] [Abstract][Full Text] [Related]
10. Effect of angiotensin converting enzyme inhibitors and angiotensin receptor blockers on serum potassium levels and renal function in ambulatory outpatients: risk factors analysis.
Maddirala S; Khan A; Vincent A; Lau K
Am J Med Sci; 2008 Oct; 336(4):330-5. PubMed ID: 18854676
[TBL] [Abstract][Full Text] [Related]
11. Predictors of hyperkalemia and death in patients with cardiac and renal disease.
Jain N; Kotla S; Little BB; Weideman RA; Brilakis ES; Reilly RF; Banerjee S
Am J Cardiol; 2012 May; 109(10):1510-3. PubMed ID: 22342847
[TBL] [Abstract][Full Text] [Related]
12. Hyperkalemia Recurrence Following Medical Nutrition Therapy in Patients with Stage 3-4 Chronic Kidney Disease: The REVOLUTIONIZE I Real-World Study.
Rowan CG; Agiro A; Chan KA; Colman E; White K; Desai P; Dwyer JP
Adv Ther; 2024 Jun; 41(6):2381-2398. PubMed ID: 38687454
[TBL] [Abstract][Full Text] [Related]
13. Association of Changes in Creatinine and Potassium Levels After Initiation of Renin Angiotensin Aldosterone System Inhibitors With Emergency Department Visits, Hospitalizations, and Mortality in Individuals With Chronic Kidney Disease.
Garlo KG; Bates DW; Seger DL; Fiskio JM; Charytan DM
JAMA Netw Open; 2018 Nov; 1(7):e183874. PubMed ID: 30646338
[TBL] [Abstract][Full Text] [Related]
14. Impact of Renin-Angiotensin Aldosterone System Inhibition on Serum Potassium Levels among Peritoneal Dialysis Patients.
Ribeiro SC; Figueiredo AE; Barretti P; Pecoits-Filho R; de Moraes TP;
Am J Nephrol; 2017; 46(2):150-155. PubMed ID: 28738355
[TBL] [Abstract][Full Text] [Related]
15. Association between serum potassium levels and adverse outcomes in chronic kidney disease: the Fukushima CKD cohort study.
Tanaka K; Saito H; Iwasaki T; Oda A; Watanabe S; Kanno M; Kimura H; Shimabukuro M; Asahi K; Watanabe T; Kazama JJ
Clin Exp Nephrol; 2021 Apr; 25(4):410-417. PubMed ID: 33411113
[TBL] [Abstract][Full Text] [Related]
16. Risk of hyperkalemia in nondiabetic patients with chronic kidney disease receiving antihypertensive therapy.
Weinberg JM; Appel LJ; Bakris G; Gassman JJ; Greene T; Kendrick CA; Wang X; Lash J; Lewis JA; Pogue V; Thornley-Brown D; Phillips RA;
Arch Intern Med; 2009 Sep; 169(17):1587-94. PubMed ID: 19786678
[TBL] [Abstract][Full Text] [Related]
17. Incidence of and risk factors for newly diagnosed hyperkalemia after hospital discharge in non-dialysis-dependent CKD patients treated with RAS inhibitors.
Saito Y; Yamamoto H; Nakajima H; Takahashi O; Komatsu Y
PLoS One; 2017; 12(9):e0184402. PubMed ID: 28877239
[TBL] [Abstract][Full Text] [Related]
18. Revisiting RAAS blockade in CKD with newer potassium-binding drugs.
Georgianos PI; Agarwal R
Kidney Int; 2018 Feb; 93(2):325-334. PubMed ID: 29276100
[TBL] [Abstract][Full Text] [Related]
19. Association of Serum Potassium with All-Cause Mortality in Patients with and without Heart Failure, Chronic Kidney Disease, and/or Diabetes.
Collins AJ; Pitt B; Reaven N; Funk S; McGaughey K; Wilson D; Bushinsky DA
Am J Nephrol; 2017; 46(3):213-221. PubMed ID: 28866674
[TBL] [Abstract][Full Text] [Related]
20. Elevated potassium levels in patients with chronic kidney disease: occurrence, risk factors and clinical outcomes-a Danish population-based cohort study.
Thomsen RW; Nicolaisen SK; Hasvold P; Sanchez RG; Pedersen L; Adelborg K; Egstrup K; Egfjord M; Sørensen HT
Nephrol Dial Transplant; 2018 Sep; 33(9):1610-1620. PubMed ID: 29177463
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
